Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier Foods Regulatory News (PFD)

Share Price Information for Premier Foods (PFD)

Share Price is delayed by 15 minutes
Get Live Data
206.00    -0.20 (-0.10%)
Bid:
206.40
Ask:
206.80
Spread: 0.40 (0.194%)
Market Cap: £1.78b
PFD Live PriceLast checked at - London Stock Exchange

Intraday Premier Foods Share Chart

Directorate Change

14 Mar 2018 13:53

RNS Number : 7373H
Premier Foods plc
14 March 2018
 

 

 

Premier Foods plc ("Premier Foods" or the "Company")

14 March 2018

 

Board Retirement

 

Premier Foods announces that Tsunao Kijima, non-executive director, has advised the Company today that he intends to stand down as a director of Premier Foods on 23 March 2018, following his decision to retire from Nissin Foods Holdings Company Ltd ("Nissin"). Mr Kijima has served on the Board since July 2016 pursuant to the terms of the Relationship Agreement between the Company and Nissin.

 

Board Appointment

 

Following Mr Kijima's retirement, Shinji Honda will be appointed as a non-executive director and as Nissin's representative director pursuant to the Relationship Agreement, with effect from 23 March 2018.

 

Mr Honda is Chief Strategy Officer of Nissin, with responsibility for overseas operations, including Europe. Prior to joining Nissin in January 2018, Mr Honda spent his entire professional career at Takeda Pharmaceutical Company Limited ("Takeda"), a leading Japanese pharmaceutical company. He was named Member of the Board of Takeda in June 2013 and Corporate Strategy Officer in October 2014, having previously spent a significant amount of time overseeing Takeda's international operations where his responsibilities included President and CEO of Takeda North America.

 

Commenting on the changes Keith Hamill, Chairman of Premier Foods, said "I would like to take this opportunity to thank Mr Kijima for his significant contribution to both the Board and the partnership between Premier and Nissin, which has helped to ensure the successful launch of a number of exciting new products to market. We welcome Mr Honda to the Board and look forward to working with him in the future".

 

Mr Honda served as Member of the Board of Takeda Pharmaceutical Company Limited (listed on the first section of the Tokyo Stock Exchange) from June 2013 until June 2017. No further information is required to be disclosed pursuant to LR 9.6.13 R.

For further information please contact:

Andrew McDonald, General Counsel & Company Secretary +44 (0) 1727 815 850

Hannah Collyer, Corporate Affairs Director +44 (0) 1727 815 850

Richard Godden, Director of Investor Relations +44 (0) 1727 815 850

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAXZLFFVXFEBBF
Date   Source Headline
1st Feb 20223:00 pmRNSDirector/PDMR Shareholding
1st Feb 202211:30 amRNSTotal Voting Rights
26th Jan 20227:00 amRNSNon-Executive Director Appointment
20th Jan 20227:00 amRNSTrading Statement
12th Jan 20227:00 amRNSApplication for Block Listing
11th Jan 20229:37 amRNSTotal Voting Rights
17th Dec 20212:00 pmRNSDirector/PDMR Shareholding
1st Dec 202111:55 amRNSTotal Voting Rights
16th Nov 20217:00 amRNSHalf-year Report
1st Nov 202111:30 amRNSTotal Voting Rights
29th Oct 20217:00 amRNSNew ESG Strategy
19th Oct 20217:00 amRNSNotice of Results
1st Oct 20212:00 pmRNSBlock listing Interim Review
1st Oct 202111:30 amRNSTotal Voting Rights
1st Sep 202111:55 amRNSTotal Voting Rights
13th Aug 202112:15 pmRNSDirector/PDMR Shareholding
13th Aug 202111:07 amRNSAppointment of Corporate Broker
2nd Aug 202111:55 amRNSTotal Voting Rights
27th Jul 20213:48 pmRNSDirector/PDMR Shareholding
23rd Jul 20212:36 pmRNSResult of AGM
23rd Jul 20217:00 amRNSQ1 Trading Update
1st Jul 202111:55 amRNSTotal Voting Rights
29th Jun 20217:00 amRNSChange to the 2021 AGM arrangements
18th Jun 20219:00 amRNSApplication for Block Listing
11th Jun 20213:04 pmRNSDirector/PDMR Shareholding
7th Jun 20212:42 pmRNSIssuance of Senior Secured Fixed Rate Notes
7th Jun 202111:03 amRNSNotice of AGM
1st Jun 202110:30 amRNSTotal Voting Rights
21st May 20212:32 pmRNS£330m Fixed Rate Notes coupon confirmed at 3.5%
20th May 202110:30 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSFinal Results
11th May 202110:30 amRNSHolding(s) in Company
10th May 202110:30 amRNSHolding(s) in Company
6th May 20217:00 amRNSNotice of Results
4th May 202110:30 amRNSTotal Voting Rights
23rd Apr 202110:30 amRNSHolding(s) in Company
14th Apr 20217:00 amRNSApplication for Block Listing
1st Apr 20219:00 amRNSBlock listing Interim Review
1st Apr 20219:00 amRNSTotal Voting Rights
26th Mar 202110:30 amRNSHolding(s) in Company
18th Mar 20213:20 pmRNSHolding(s) in Company
12th Mar 20218:44 amRNSHolding(s) in Company
2nd Mar 20213:30 pmRNSDirector Declaration
1st Mar 202111:52 amRNSTotal Voting Rights
19th Feb 20217:00 amRNSDirectorate Change
18th Feb 20217:00 amRNSPartial redemption of Senior Secured Notes
12th Feb 20219:00 amRNSReduction of Capital
2nd Feb 202112:06 pmRNSDirector/PDMR Shareholding
1st Feb 20219:05 amRNSTotal Voting Rights
28th Jan 202110:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.